|
 |
 |
 |
About 3 million Americans experience
a whiplash injury (cervical acceleration/deceleration—CAD) each year (1). CAD trauma
is also the most common cause of mild traumatic brain injury
(MTBI) in the U.S. (1). Many of these patients will go on to
develop postconcussion syndrome (PCS), which can become chronic
and, in some cases, disabling. Recent studies have also shown
a strong association between brain injury and a permanent loss
of IQ, along with the latter development of depression and neurodegenerative
disorders, such as Parkinson’s and Alzheimer’s disease.
The most common symptoms of MTBI include easy distractibility,
forgetfulness, and difficulty concentrating. Most patients also
complain of sleep disturbances, memory problems, alterations
in mood, and diminished tolerance to stress, family members,
coworkers, etc. Dr.
Arthur C. Croft, has been writing about MTBI/PCS for more than
15 years (1-11), becoming keenly
interested after his
own MTBI in 1992. He’s reported that this type of brain
injury is not so much an acute, immediate event, as it is a
progressive sequence of destructive cellular events—triggered
by the trauma—which unfold over time. This corrosive
cascade is catalyzed at the cellular level by free radical
oxidative reactions and lipid peroxidation, leading, ultimately,
to neuron death. (For an in-depth look at this phenomenon,
see reference 1, p535-537).
The key to preventing or limiting
this process is to support the CNS with sufficient quantities
of high-quality antioxidants,
including vitamins E, C, and A (betacarotene), along with bioflavonoids,
zinc, selenium, and super oxide dismutase, in addition to those
nutrients known to be critical for CNS function, such as the
B vitamins, biotin, inositol, and choline. Ginkgo biloba was
added to the formula because of its proven capacity as an antioxidant
and for enhancing cognitive function, increasing ATP and serotonin
levels and the brain’s tolerance to low oxygen levels,
and for its capacity to improve glucose utilization.
Neuronostat-gB provides an excellent
routine CNS support for optimum cognitive function in all
adults, and a compelling
prevention strategy against the common neurodegenerative disorders
associated with aging—even in persons without prior brain
injury.
Dosage: 2-3 capsules/day, between meals. |
| 1. |
|
Croft AC: Soft tissue injuries: the long- and short-term
effects. In Foreman SM, Croft AC (eds): Whiplash
Injuries: The Cervical Acceleration/Deceleration
Syndrome (ed 3). Baltimore, Lippincott Williams & Wilkins
Co., 2001, p360. |
| 2. |
|
Croft AC, Krage JS, Remsen
WH: The postconcussion syndrome. Trial Bar News (SDTLA),
9(4):26, April 1987. |
| 3. |
|
Croft AC: Minor head injuries
and the post concussion syndrome. San Diego County
Chiropractic Society Bulletin, 10(1): 5-15, January,
1988. |
| 4. |
|
Croft AC: Whiplash and brain
injuries: cognitive defect or fertile imagination?
Dynamic Chiropractic, 10(7): 10-35, 1992. |
| 5. |
|
Croft AC: The post-concussion
syndrome (PCS): what’s new? Part I. Texas Chiropractic
Journal,10(7): 29-31, 1993. |
| 6. |
|
Croft AC: The post-concussion
syndrome (PCS): what’s new? Part II. Texas
Chiropractic Journal, 10(8):27-29, 1993. |
| 7. |
|
Croft AC: Mild traumatic brain
injuries after motor vehicle accidents. Dynamic Chiropractic
12(6):9-35, 1994. |
| 8. |
|
Croft AC: Cognitive deficits
following cervical spine trauma. Texas J Chiropractic
12(8):31, 1995. |
| 9. |
|
Croft AC: Postconcussion syndrome
following motor vehicle trauma: new literature. Florida
Chiropractic Assoc J 43-45, March-April, 1995.10.
Croft AC: The potential role of antioxidant-based
therapeutic intervention in the management of traumatic
brain injury. Dynamic Chiropractic 15(25):4-42, 1997. |
| 10. |
|
Croft AC: The current roles
of SPECT and PET in the diagnosis of brain injury.
Dynamic Chiropractic 16(25):34-43, 1998. |
These claims have not been evaluated by the FDA. These
products are not intended to treat, prevent, cure,
or diagnose disease.
> Please
call (800) 423-9860 or (619) 660-8802
for pricing. Physicians only.
|
|
|
|
|
Serving Size 3 capsules
Servings per container 30 |
|
Amount Per Serving |
| |
|
|
| Vitamin A (as beta carotene) |
|
5000 IU |
| Ascorbic Acid |
|
500 mg |
| Vitamin E (as d-alpha tocopherol
succinate) |
|
250 IU |
| Vitamin K (as phytonadione) |
|
100 mcg |
| Thiamine (as Thiamine HCl) |
|
100 mg |
| Riboflavin |
|
100 mg |
| Niacinamide |
|
100 mg |
| Vitamin B6 (as Pyridoxine HCl) |
|
100 mcg |
| Folic Acid |
|
400 mcg |
| Vitamin B12 (as cyanocobalamin) |
|
100 mcg |
| Biotin |
|
50 mcg |
| Pantothenic Acid (as d-Calcium
Pantothenate) |
|
100 mg |
| Calcium (as Hydroxyapatite) |
|
250 mg |
| Zinc (as Chelazome) |
|
25 mg |
| Selenium (as Amino acid chelate) |
|
250 mcg |
Ginkgo Biloba Leaf Extract
(Standardized to contain 25% Ginkgoflavone
glycosindes and
6% Terpene Lactones) |
|
250 mg |
| Citrus Bioflavonoids |
|
200 mg |
| Inositol |
|
100 mg |
| Choline Bitartrate |
|
100 mg |
| Super Oxide dismutase |
|
1 mg |
|
|
Spine Research Institute of San Diego, Inc.
826 Orange Avenue, Suite 633
 Coronado, CA 92118
USA
Voice: (800) 423-9860 or (619) 660-8802
Monday-Friday 9:00 am- 5:00 pm (PST)
Fax: (619) 660-8809
Email: info@srisd.com |
